The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
Open accessAbstract
Cancer-related anemia (CRA) is a common sign occurring in more than 30% of cancer patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant influence on survival, disease progression, treatment efficacy, and the patients' quality of life. It is more often detected in patients with advanced stage disease, where it represents a specific symptom of the neoplastic disease, as a consequence of chronic inflammation. In fact, CRA is characterized by biological and hematologic features that resemble those described in anemia associated to chronic inflammatory disease. Proinflammatory cytokine, mainly IL-6, which are released by both tumor and immune cells, play a pivotal action in CRA etiopathogenesis: they promote alterations in erythroid progenitor proliferation, erythropoietin (EPO) production, survival of circulating erythrocytes, iron balance, redox status, and energy metabolism, all of which can lead to anemia. The discovery of hepcidin allowed a greater knowledge of the relationships between immune cells, iron metabolism, and anemia in chronic inflammatory diseases. Additionally, chronic inflammation influences a compromised nutritional status, which in turn might induce or contribute to CRA. In the present review we examine the multifactorial pathogenesis of CRA discussing the main and novel mechanisms by which immune, nutritional, and metabolic components affect its onset and severity. Moreover, we analyze the status of the art and the perspective for the treatment of CRA. Notably, despite the high incidence and clinical relevance of CRA, controlled clinical studies testing the most appropriate treatment for CRA are scarce, and its management in clinical practice remains challenging. The present review may be useful to indicate the development of an effective approach based on a detailed assessment of all factors potentially involved in the pathogenesis of CRA. This mechanism-based approach is essential for clinicians to plan a safe, targeted, and successful therapy, thereby promoting a relevant amelioration of patients' quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096
Regulation of ferritin genes and protein
Torti, F. M., & Torti, S. V. (2002) · Blood · doi:10.1182/blood.v99.10.3505 · Cited by 1,173 · cited 1×
“These peculiar changes have been attributed to the increased synthesis of hepcidin from hepatocytes induced by inflammatory cytokines, mainly IL-6 (Alvarez-Hernandez et al., 1989; Torti and Torti, 2002).”
BackgroundIdentification of erythroferrone as an erythroid regulator of iron metabolism
Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127 · cited 1×
“More recently, erythroferrone has been described as an additional regulator of hepcidin: it is synthesized by erythroblasts stimulated by EPO and inhibit hepcidin production, this in turn enables export of intracellular iron and intestinal iron absorption, thus allowing erythropoiesis (Kautz et al., 2014).”
BackgroundPrevalence and outcomes of anemia in cancer: a systematic review of the literature
Knight, K., Wade, S., & Balducci, L. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.12.008 · Cited by 878
Iron homeostasis in host defence and inflammation
Ganz, T., & Nemeth, E. (2015) · Nature Reviews Immunology · doi:10.1038/nri3863 · Cited by 843 · cited 3×
“Circulating iron is delivered inside cells (macrophages of the reticulo-endothelial system) by endocytosis of transferrin and is stored in complex with ferritin (Ganz and Nemeth, 2015).”
BackgroundInfluentialUnderstanding cachexia as a cancer metabolism syndrome
Porporato, P. E. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.3 · Cited by 562
Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors
Sitkovsky, M., & Lukashev, D. (2005) · Nature Reviews Immunology · doi:10.1038/nri1685 · Cited by 518
Research works printed but not linked: 190
- Aapro, 2009, Epoetin-beta treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events., Br. J. Cancer., 101, 1961, 10.1038/sj.bjc.6605255 · DOI
- Abella, 2017, Leptin in the interplay of inflammation, metabolism and immune system disorders., Nat. Rev. Rheumatol., 13, 100, 10.1038/nrrheum.2016.209 · DOI · Paper page
- Adamson, 2008, The anemia of inflammation/malignancy: mechanisms and management., Hematol. Am. Soc. Hematol. Educ. Program, 2008, 159, 10.1182/asheducation-2008.1.159 · DOI
- Alvarez-Hernandez, 1989, Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor., Lab. Invest., 61, 319
- An, 2015, T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy., World J. Surg. Oncol., 13, 10.1186/s12957-015-0488-7 · DOI
- Argilés, 2014, Cancer cachexia: understanding the molecular basis., Nat. Rev. Cancer, 14, 754, 10.1038/nrc3829 · DOI · Paper page
- Auerbach, 2004, Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial., J. Clin. Oncol., 22, 1301, 10.1200/JCO.2004.08.119 · DOI · Paper page
- Axelsson, 2005, Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD., Am. J. Kidney Dis., 46, 628, 10.1053/j.ajkd.2005.06.004 · DOI
- Baribeault, 2011, Iron replacement therapy in cancer-related anemia., Am. J. Health Syst. Pharm., 68, S4, 10.2146/ajhp110039 · DOI
- Basseri, 2012, Hepcidin is a key mediator of anemia of inflammation in Crohn’s disease., J. Crohns Colitis, 7, e286, 10.1016/j.crohns.2012.10.013 · DOI
- Bastit, 2008, Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia., J. Clin. Oncol., 26, 1611, 10.1200/JCO.2006.10.4620 · DOI · Paper page
- Bayliss, 2011, A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer., Expert. Opin. Biol. Ther., 11, 1663, 10.1517/14712598.2011.627850 · DOI · Paper page
- Beguin, 1998, Prediction of response to optimize outcome of treatment with erythropoietin., Semin. Oncol., 25, 27
- Benedik, 2014, The physiologic role of erythrocytes in oxygen delivery and implications for blood storage., Crit. Care Nurs. Clin. North Am., 26, 325, 10.1016/j.ccell.2014.04.002 · DOI
- Bennett, 2008, Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia., JAMA, 299, 914, 10.1001/jama.299.8.914 · DOI · Paper page
- Bennett, 1981, Homeostatic removal of senescent murine erythrocytes by splenic macrophages., Exp. Hematol., 9, 297
- Bertero, 1997, Anemia of chronic disorders in systemic autoimmune diseases., Haematologica, 82, 375
- Bing, 2006, Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice., Br. J. Cancer, 95, 1028, 10.1038/sj.bjc.6603360 · DOI · Paper page
- Birgegård, 2005, Cancer-related anemia: pathogenesis, prevalence and treatment., Oncology, 68, 3, 10.1159/000083128 · DOI · Paper page
- Bistrian, 2000, Impact of inflammation on nutrition, iron status, and erythropoietin responsiveness in ESRD patients., Nephrol. Nurs. J., 27, 616
- Blackwell, 2004, rHuEPO and improved treatment outcomes: potential modes of action., Oncologist, 9, 41, 10.1634/theoncologist.9-90005-41 · DOI
- Bogdanos, 2004, Epoetin beta (NeoRecormon) corrects anaemia in patients with hormone-refractory prostate cancer and bone metastases., Anticancer Res., 24, 1957
- Bohlius, 2009, Erythropoietin or Darbepoetin for patients with cancer–meta-analysis based on individual patient data., Cochrane Database Syst. Rev., 3, 10.1002/14651858.CD007303.pub2 · DOI
- Bohlius, 2014, Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data., Br. J. Cancer, 111, 33, 10.1038/bjc.2014.171 · DOI
- Bohlius, 2006, Cancer-related anemia and recombinant human erythropoietin–an updated overview., Nat. Clin. Pract. Oncol., 3, 152, 10.1038/ncponc0451 · DOI
- Boushel, 2017, Linking skeletal muscle blood flow and metabolism to the limits of human performance., Appl. Physiol. Nutr. Metab., 42, 111, 10.1139/apnm-2016-0393 · DOI
- Bron, 2001, Biological basis of anemia., Semin. Oncol., 28, 1, 10.1016/S0093-7754(01)90205-2 · DOI
- Brown, 2010, Assessment of fatigue after blood transfusion in palliative care patients: a feasibility study., J. Palliat. Med., 13, 1327, 10.1089/jpm.2010.0143 · DOI
- Brown, 2007, Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity., Stem Cells, 25, 718, 10.1634/stemcells.2006-0687 · DOI
- Buemi, 2003, The pleiotropic effects of erythropoietin in the central nervous system., J. Neuropathol. Exp. Neurol., 62, 228, 10.1093/jnen/62.3.228 · DOI
- Bukowska, 2015, Oxidative stress and damage to erythrocytes in patients with chronic obstructive pulmonary disease–changes in ATPase and acetylcholinesterase activity., Biochem. Cell. Biol., 93, 574, 10.1139/bcb-2015-0066 · doi:10.1139/bcb-2015-0066
- Burke, 2015, IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB., Am. J. Physiol. Endocrinol. Metab., 309, E715, 10.1152/ajpendo.00153.2015 · DOI
- Camaschella, 2008, Recent advances in the understanding of inherited sideroblastic anaemia., Br. J. Haematol., 143, 27, 10.1111/j.1365-2141.2008.07290.x · DOI
- Camaschella, 2016, The mutual control of iron and erythropoiesis., Int. J. Lab. Hematol., 38, 20, 10.1111/ijlh.12505 · DOI
- Carbó, 1994, Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model., Clin. Sci., 87, 349, 10.1042/cs0870349 · doi:10.1042/cs0870349
- Caro, 2001, Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review., Cancer, 91, 2214, 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P · DOI · Paper page
- Carson, 2016, Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage., JAMA, 316, 2025, 10.1001/jama.2016.9185 · DOI · Paper page
- Cawthorn, 2008, TNF-α and adipocyte biology., FEBS Lett., 582, 117, 10.1016/j.febslet.2007.11.051 · DOI · Paper page
- Cella, 1998, Factors influencing quality of life in cancer patients: anemia and fatigue., Semin. Oncol., 25, 43
- Chamogeorgakis, 2008, Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment?, Thorac. Cardiovasc. Surg., 56, 148, 10.1055/s-2007-989455 · doi:10.1055/s-2007-989455
- Chiabrando, 2014, Heme and erythropoieis: more than a structural role., Haematologica, 99, 973, 10.3324/haematol.2013.091991 · DOI · Paper page
- Christ, 1997, The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency., J. Clin. Endocrinol. Metab., 82, 2985
- Chung, 2015, The mTORC1/4E-BP pathway coordinates hemoglobin production with L-leucine availability., Sci. Signal., 8, 10.1126/scisignal.aaa5903 · DOI
- Coward, 2011, Interleukin-6 as a therapeutic target in human ovarian cancer., Clin. Cancer Res., 17, 6083, 10.1158/1078-0432.CCR-11-0945 · DOI · Paper page
- Crawford, 2002, Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy., Cancer, 95, 888, 10.1002/cncr.10763 · DOI · Paper page
- Cybulska, 2017, Indications for and complications of transfusion and the management of gynecologic malignancies., Gynecol. Oncol., 146, 416, 10.1016/j.ygyno.2017.05.010 · DOI
- Daneryd, 1998, Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study., Cancer Res., 58, 5374
- Delano, 2006, The origins of cachexia in acute and chronic inflammatory diseases., Nutr. Clin. Pract., 21, 68, 10.1177/011542650602100168 · DOI · Paper page
- Doty, 2015, Coordinate expression of heme and globin is essential for effective erythropoiesis., J. Clin. Invest., 125, 4681, 10.1172/JCI83054 · DOI
- Doulatov, 2012, Hematopoiesis: a human perspective., Cell Stem Cell, 10, 120, 10.1016/j.stem.2012.01.006 · DOI · Paper page
- Dunn, 2003, Anemia at the end of life: prevalence, significance and causes in patients receiving palliative care., J. Pain Symptom Manage., 26, 1132, 10.1016/j.jpainsymman.2003.04.001 · DOI
- Faquin, 1992, Effect of inflammatory cytokines on hypoxia-induced erythropoietin production., Blood, 79, 1987, 10.1182/blood.V79.8.1987.1987 · DOI · Paper page
- Fearon, 2011, Definition and classification of cancer cachexia: an international consensus., Lancet. Oncol., 12, 489, 10.1016/S1470-2045(10)70218-7 · DOI · Paper page
- Finch, 1982, Erythropoiesis, erythropoietin, and iron., Blood, 60, 1241, 10.1182/blood.V60.6.1241.1241 · DOI
- Fishbane, 2000, The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate., Semin. Dial., 13, 381, 10.1046/j.1525-139x.2000.00104.x · DOI
- Friesen, 2015, Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia., Theor. Biol. Med. Model., 12, 10.1186/s12976-015-0015-0 · DOI
- Fuso, 2005, Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report., Gynecol. Oncol., 99, S187, 10.1016/j.ygyno.2005.07.079 · doi:10.1016/j.ygyno.2005.07.079
- Gaspar, 2015, Anemia in malignancies: pathogenetic and diagnostic considerations., Hematology, 20, 18, 10.1179/1607845414Y.0000000161 · DOI
- Gautron, 2010, Neurobiology of inflammation-associated anorexia., Front. Neurosci., 3, 10.3389/neuro.23.003.2009 · DOI
- Ghezzi, 2007, Activities of erythropoietin on tumors: an immunological perspective., Eur. J. Immunol., 37, 1427, 10.1002/eji.200737401 · DOI · Paper page
- Gleason, 1995, Blood transfusion and its benefits in palliative care., Palliat. Med., 9, 307, 10.1177/026921639500900405 · doi:10.1177/026921639500900405
- Goldberg, 2008, FDA orders more changes in ESA label, agents not indicated in curative setting., Cancer Lett., 34, 1
- Goodnough, 2005, Risks of blood transfusion., Anesthesiol. Clin. North Am., 23, 241, 10.1016/j.atc.2004.07.004 · doi:10.1016/j.atc.2004.07.004
- Gordon, 2008, Treating anemia of cancer with every-4-week darbepoetin alfa: final efficacy and safety results from a phase II, randomized, double-blind, placebo-controlled study., Oncologist, 13, 715, 10.1634/theoncologist.2007-0241 · DOI
- Grant, 2013, Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update
- Grogan, 1999, The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix., Cancer, 86, 1528, 10.1002/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E · DOI
- Haag-Weber, 2012, Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study., Clin. Nephrol., 77, 8, 10.5414/CN107304 · DOI
- Hagerty, 2008, Continued regulatory actions affecting the use of erythropoiesis-stimulating agents., J. Oncol. Pract., 4, 267, 10.1200/JOP.0863501 · doi:10.1200/jop.0863501
- Halstenson, 1991, Abraham PA. Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta., Clin. Pharmacol. Ther., 50, 702, 10.1038/clpt.1991.210 · DOI · Paper page
- Hare, 2014, Tolerance of anemia: understanding the adaptive physiological mechanisms which promote survival., Transfus. Apher. Sci., 50, 10, 10.1016/j.transci.2013.12.005 · DOI
- Hare, 2008, Anemia and cerebral outcomes: many questions, fewer answers., Anesth. Analg., 107, 1356, 10.1213/ane.0b013e318184cfe9 · DOI
- Harrison, 2004, Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?, Oncologist, 9, 31, 10.1634/theoncologist.9-90005-31 · DOI · Paper page
- Henke, 2003, Erythropoietin to treat head and neck cancer patients with anaemia undergoing radio-therapy: randomised, double-blind, placebo-controlled trial., Lancet, 362, 1255, 10.1016/S0140-6736(03)14567-9 · DOI · Paper page
- Henke, 2006, Do erythropoietin receptors on cancer cells explain unexpected clinical findings?, J. Clin. Oncol., 24, 4708, 10.1200/JCO.2006.06.2737 · DOI · Paper page
- Henry, 2010, Parenteral iron therapy in cancer-associated anemia., Hematol. Am. Soc. Hematol. Educ. Program, 2010, 351, 10.1182/asheducation-2010.1.351 · doi:10.1182/asheducation-2010.1.351
- Henry, 2007, Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy., Oncologist, 12, 231, 10.1634/theoncologist.12-2-231 · DOI · Paper page
- Höckel, 2001, Biological consequences of tumor hypoxia., Semin. Oncol., 28, 36, 10.1016/S0093-7754(01)90211-8 · DOI · Paper page
- Hung, 2005, High-calorie supplementation increases serum leptin levels and improves response to rHuEPO in long-term hemodialysis patients., Am. J. Kidney Dis., 45, 1073, 10.1053/j.ajkd.2005.02.020 · DOI
- Iglesias, 1998, Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study., Am. J. Kidney Dis., 32, 454, 10.1053/ajkd.1998.v32.pm9740162 · DOI
- Jelkmann, 1992, Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys., Life Sci., 50, 301, 10.1016/0024-3205(92)90338-P · DOI · Paper page
- Jelkmann, 2010, Biosimilar epoetins and other “follow-on” biologics: update on the European experiences., Am. J. Hematol., 85, 771, 10.1002/ajh.21805 · DOI
- Jewell, 2001, Induction of HIF-1 alpha in response to hypoxia is instantaneous., FASEB J., 15, 1312, 10.1096/fj.00-0732fje · DOI · Paper page
- Juneja, 2008, Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer., Clin. Cancer Res., 14, 3242, 10.1158/1078-0432.CCR-07-1872 · doi:10.1158/1078-0432.ccr-07-1872
- Kader, 2007, Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy., Am. J. Clin. Oncol., 30, 492, 10.1097/01.coc.0000264177.66369.18 · doi:10.1097/01.coc.0000264177.66369.18
- Kalantar-Zadeh, 2001, A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients., Am. J. Kidney Dis., 38, 1251, 10.1053/ajkd.2001.29222 · DOI · Paper page
- Katz, 2007, Neumann D. Erythropoietin enhances immune responses in mice., Eur. J. Immunol., 37, 1584, 10.1002/eji.200637025 · DOI
- Khorana, 2008, Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer., Arch. Intern. Med., 168, 2377, 10.1001/archinte.168.21.2377 · DOI · Paper page
- Kling, 1996, Iron deprivation increases erythropoietin production in vitro, in normal subjects and patients with malignancy., Br. J. Haematol., 95, 241, 10.1046/j.1365-2141.1996.d01-1919.x · DOI
- Ladányi, 2004, T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma., Clin. Cancer Res., 10, 521, 10.1158/1078-0432.CCR-1161-03 · DOI
- Lang, 2014, Oxidative stress and suicidal erythrocyte death., Antioxid. Redox Signal., 21, 138, 10.1089/ars.2013.5747 · DOI · Paper page
- Leyland–Jones, 2005, Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study., J. Clin. Oncol., 23, 5960, 10.1200/JCO.2005.06.150 · DOI · Paper page
- Lindholm, 2004, Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients., Clin. Cancer Res., 10, 6855, 10.1158/1078-0432.CCR-04-0373 · DOI
- Ludwig, 2009, Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study., Eur. J. Cancer, 45, 1603, 10.1016/j.ejca.2009.02.003 · DOI
- Ludwig, 2001, Symptomatology of anemia., Semin. Oncol., 28, 7, 10.1016/S0093-7754(01)90206-4 · DOI · Paper page
- Ludwig, 2004, The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients., Eur. J. Cancer, 40, 2293, 10.1016/j.ejca.2004.06.019 · DOI · Paper page
- Lundholm, 2004, Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function., Cancer, 100, 1967, 10.1002/cncr.20160 · DOI · Paper page
- Macciò, A multitargeted treatment approach for anemia and cachexia in metastatic castration-resistant prostate cancer., J. Pain Symptom Manage., 50, e1, 10.1016/j.jpainsymman.2015.04.014 · doi:10.1016/j.jpainsymman.2015.04.014
- Macciò, Surprising results of a supportive integrated therapy in myelofibrosis., Nutrition, 31, 239, 10.1016/j.nut.2014.07.016 · doi:10.1016/j.nut.2014.07.016
- Macciò, The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study., Haematologica, 100, 124, 10.3324/haematol.2014.112813 · DOI · Paper page
- Macciò, 1998, High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer., Gynecol. Oncol., 69, 248, 10.1006/gyno.1998.4974 · DOI
- Macciò, 2012, Inflammation and ovarian cancer., Cytokine, 58, 133, 10.1016/j.cyto.2012.01.015 · DOI · Paper page
- Macciò, 2012, A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life., Gynecol. Oncol., 124, 417, 10.1016/j.ygyno.2011.12.435 · DOI
- Macciò, 2010, Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-β for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study., Oncologist, 15, 894, 10.1634/theoncologist.2010-0020 · DOI
- Macciò, 2009, Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients., J. Cell. Mol. Med., 13, 3951, 10.1111/j.1582-4934.2008.00408.x · DOI
- Macciò, 2005, Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia., Blood, 106, 362, 10.1182/blood-2005-01-0160 · DOI · Paper page
- Madeddu, 2014, Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer., J. Cell. Mol. Med., 18, 2519, 10.1111/jcmm.12413 · DOI
- Madeddu, 2018, Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: key role of Interleukin-6., Haematologica, 10.3324/haematol.2018.191551 · DOI
- Madeddu, 2015, Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches., Future Oncol., 10.2217/fon.15.195 · DOI
- Mantovani, 2003, Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress., J. Mol. Med., 81, 664, 10.1007/s00109-003-0476-1 · DOI
- Mantovani, 2001, Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites., J. Mol. Med., 79, 406, 10.1007/s001090100234 · DOI
- Marini, 2017, A polymorphism at IGF1 locus is associated with anemia., Oncotarget, 8, 32398, 10.18632/oncotarget.16132 · DOI
- Martin, 2015, Diagnostic criteria for the classification of cancer-associated weight loss., J. Clin. Oncol., 33, 90, 10.1200/JCO.2014.56.1894 · DOI · Paper page
- McCammon, 2003, Global transcription analysis of Krebs tricarboxylic acid cycle mutants reveals an alternating pattern of gene expression and effects on hypoxic and oxidative genes., Mol. Biol. Cell., 14, 958, 10.1091/mbc.e02-07-0422 · DOI
- McCranor, 2014, Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells., Blood Cells Mol. Dis., 52, 126, 10.1016/j.bcmd.2013.09.004 · DOI
- McMillan, 2009, Systemic inflammation, nutritional status and survival in patients with cancer., Curr. Opin. Clin. Nutr. Metab. Care, 12, 223, 10.1097/MCO.0b013e32832a7902 · DOI · Paper page
- Means, 1995, Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia., Stem Cells, 13, 32, 10.1002/stem.5530130105 · DOI · Paper page
- Means, 2003, Recent developments in the anemia of chronic disease., Curr. Hematol. Rep., 2, 116
- Mercadante, 2009, Effects of red blood transfusion on anemia-related symptoms in patients with cancer., J. Palliat. Med., 12, 60, 10.1089/jpm.2008.0139 · DOI
- Mhaskar, 2016, The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis stimulating agents., Cochrane Database Syst. Rev., 2, 10.1002/14651858.CD009624.pub2 · DOI
- Michallet, 2016, Biosimilar epoetin zeta in oncology and haematology: development and experience following 6 years of use., Acta Haematol., 135, 44, 10.1159/000438976 · doi:10.1159/000438976
- Miller, 2008, Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer., J. Clin. Oncol., 26, 971, 10.1200/JCO.2007.10.7805 · DOI · Paper page
- Millonig, 2012, Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3)., J. Biol. Chem., 287, 37472, 10.1074/jbc.M112.358911 · DOI
- Molnar, 2011, Association between the malnutrition-inflammation score and post-transplant anaemia., Nephrol. Dial. Transplant., 26, 2000, 10.1093/ndt/gfq690 · DOI
- Montel-Hagen, 2009, Erythroid glucose transporters., Curr. Opin. Hematol., 16, 165, 10.1097/MOH.0b013e328329905c · DOI
- Mystakidou, 2005, Evaluation of epoetin supplemented with oral iron in patients with solid malignancies and chronic anemia not receiving anticancer treatment., Anticancer Res., 25, 3495
- Nagasawa, 2005, Pivotal role of peroxisome proliferator-activated receptor gamma (PPARgamma) in regulation of erythroid progenitor cell proliferation and differentiation., Exp. Hematol., 33, 857, 10.1016/j.exphem.2005.05.003 · DOI
- Nathan, 2015, Amino acid uptake in erythropoiesis., Sci. Signal., 8, 10.1126/scisignal.aab1203 · doi:10.1126/scisignal.aab1203
- Nekoui, 2017, Erythropoietin and nonhematopoietic effects., Am. J. Med. Sci., 353, 76, 10.1016/j.amjms.2016.10.009 · DOI
- Newland, 2008, Tumor progression associated with erythropoiesis-stimulating agents., Ann. Pharmacother., 42, 1865, 10.1345/aph.1L231 · doi:10.1345/aph.1l231
- Nicolas, 2002, Severe iron deficiency anemia in transgenic mice expressing liver hepcidin., Proc. Natl. Acad. Sci. U.S.A., 99, 4596, 10.1073/pnas.072632499 · DOI · Paper page
- Nieken, 1995, Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients., Blood, 86, 900, 10.1182/blood.V86.3.900.900 · DOI · Paper page
- Nilsson-Ehle, 2005, Insulin-like growth factor-1 is a predictor of blood haemoglobin concentration in 70-yr-old subjects., Eur. J. Haematol., 74, 111, 10.1111/j.1600-0609.2004.00374.x · DOI
- Obermair, 1998, The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review., Cancer, 83, 726, 10.1002/(SICI)1097-0142(19980815)83:4<726::AID-CNCR14>3.0.CO;2-U · doi:10.1002/(sici)1097-0142(19980815)83:4<726::aid-cncr14>3.0.co;2-u
- Oburoglu, 2016, Metabolic regulation of hematopoietic stem cell commitment and erythroid differentiation., Curr. Opin. Hematol., 23, 198, 10.1097/MOH.0000000000000234 · DOI
- Oburoglu, 2014, Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification., Cell Stem Cell, 15, 169, 10.1016/j.stem.2014.06.002 · DOI · Paper page
- Olszewska, 2012, Oxidative stress modulates the organization of erythrocyte membrane cytoskeleton., Postepy Hig. Med. Dosw., 66, 534, 10.5604/17322693.1005677 · doi:10.5604/17322693.1005677
- Palis, 2014, Primitive and definitive erythropoiesis in mammals., Front. Physiol., 5, 10.3389/fphys.2014.00003 · DOI · Paper page
- Patel, 2017, TNF-α and cancer cachexia: molecular insights and clinical implications., Life Sci., 170, 56, 10.1016/j.lfs.2016.11.033 · DOI · Paper page
- Patra, 2012, Integrative role of neuropeptides and cytokines in cancer anorexia-cachexia syndrome., Clin. Chim. Acta, 413, 1025, 10.1016/j.cca.2011.12.008 · DOI
- Pedrazzoli, 2008, Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha., J. Clin. Oncol., 26, 1619, 10.1200/JCO.2007.12.2051 · DOI · Paper page
- Preston, 2012, Blood transfusions for anaemia in patients with advanced cancer., Cochrane Database Syst. Rev., 2, 10.1002/14651858.CD009007.pub2 · DOI
- Prince, 2012, Late stage erythroid precursor production is impaired in mice with chronic inflammation., Haematologica, 97, 1648, 10.3324/haematol.2011.053397 · DOI
- Pronzato, 2006, Cancer-related anaemia management in the 21st century., Cancer Treat. Rev., 32, S1, 10.1016/j.ctrv.2006.04.008 · DOI
- Quirt, 2001, Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy., J. Clin. Oncol., 19, 4126, 10.1200/JCO.2001.19.21.4126 · DOI
- Rattanasompattikul, 2013, Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients., Nephrol. Dial. Transplant., 28, 1936, 10.1093/ndt/gfs368 · DOI
- Reglin, 2009, Structural adaptation of microvessel diameters in response to metabolic stimuli: where are the oxygen sensors?, Am. J. Physiol. Heart Circ. Physiol., 297, H2206, 10.1152/ajpheart.00348.2009 · DOI
- Ribeiro, 2016, Pathological and molecular mechanisms underlying resistance to recombinant human erythropoietin therapy in the remnant kidney rat model of chronic kidney disease associated anemia., Biochimie, 125, 150, 10.1016/j.biochi.2016.03.012 · DOI
- Rizzo, 2010, American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer., Blood, 116, 4045, 10.1182/blood-2010-08-300541 · DOI · Paper page
- Rodgers, 2017, NCCN. Cancer- and Chemotherapy-Induced Anemia, Version 2.2017
- Sailaja, 2003, The antioxidant status during maturation of reticulocytes to erythrocytes in type 2 diabetics., Free. Radic. Biol. Med., 35, 133, 10.1016/S0891-5849(03)00071-6 · DOI
- Saini, 2006, Waste management - cytokines, growth factors and cachexia., Cytokine Growth Factor Rev., 17, 475, 10.1016/j.cytogfr.2006.09.006 · DOI · Paper page
- Sandler, 1990, Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro., Endocrinology, 126, 1288, 10.1210/endo-126-2-1288 · DOI
- Sanz Ortiz, 2008, Predictors of response to erythropoiesis-stimulating agents (ESA) in cancer patients: the role of baseline serum epoetin level., Clin. Transl. Oncol., 10, 486, 10.1007/s12094-008-0237-2 · DOI
- Schmidt, 2015, Regulation of iron metabolism by hepcidin during conditions of inflammation., J. Biol. Chem., 290, 18975, 10.1074/jbc.R115.650150 · DOI · Paper page
- Schwartz, 2007, Anemia in patients with cancer: incidence, causes, impact, management, and use of treatment guidelines and protocols., Am. J. Health Syst. Pharm., 64, S5, 10.2146/ajhp060601 · DOI
- Semenza, 2000, Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1., J. Clin. Invest., 106, 809, 10.1172/JCI11223 · DOI · Paper page
- Shasha, 2001, The negative impact of anemia on radiotherapy and chemoradiation outcomes., Semin. Hematol., 38, 8, 10.1016/S0037-1963(01)90125-8 · DOI
- Shin, 2014, Prognostic value of pretreatment hemoglobin level in patients with early cervical cancer., Obstet. Gynecol. Sci., 57, 28, 10.5468/ogs.2014.57.1.28 · doi:10.5468/ogs.2014.57.1.28
- Shu, 2014, Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis., Eur. J. Haematol., 94, 67, 10.1111/ejh.12402 · DOI
- Simon, 1998, Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists., Arch. Pathol. Lab. Med., 122, 130
- Smith, 2008, Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study., J. Clin. Oncol., 26, 1040, 10.1200/JCO.2007.14.2885 · DOI · Paper page
- Spivak, 2000, The blood in systemic disorders., Lancet, 355, 1707, 10.1016/S0140-6736(00)02249-2 · DOI
- Spivak, 2005, The anaemia of cancer: death by a thousand cuts., Nat. Rev. Cancer, 5, 543, 10.1038/nrc1648 · DOI · Paper page
- Spivak, 2011, Iron and the anemia of chronic disease: vindication for the Non-essential role of iron supplementation., Oncology, 25, 421
- Spivak, 2009, Anemia management in oncology and hematology., Oncologist, 14, 43, 10.1634/theoncologist.2009-S1-43 · DOI
- Steensma, 2008, Is anemia of cancer different from chemotherapy-induced anemia?, Clin. Oncol., 26, 1022, 10.1200/JCO.2007.15.3874 · doi:10.1200/jco.2007.15.3874
- Steensma, 2011, Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia., J. Clin. Oncol., 29, 97, 10.1200/JCO.2010.30.3644 · DOI
- Storring, 1998, Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties., Br. J. Haematol., 100, 79, 10.1046/j.1365-2141.1998.00521.x · DOI · Paper page
- Strassmann, 1992, Evidence for the involvement of interleukin 6 in experimental cancer cachexia., J. Clin. Invest., 89, 1681, 10.1172/JCI115767 · DOI · Paper page
- Succurro, 2011, Low insulin-like growth factor-1 levels are associated with anaemia in adult non-diabetic subjects., Thromb. Haemost., 105, 365, 10.1160/TH10-06-0379 · DOI
- Takeda, 2002, Factors contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin., Am. J. Kidney Dis., 40, 104, 10.1053/ajkd.2002.33918 · DOI
- Tanneberger, 2004, Use of red blood cell transfusion in palliative care services: it is still up to date or is cancer-related anemia controlled better with erythropoietic agents?, Ann. Oncol., 15, 839, 10.1093/annonc/mdh178 · doi:10.1093/annonc/mdh178
- Tarng, 1999, Erythropoietin hyporesponsiveness: from iron deficiency to iron overload., Kidney Int. Suppl., 69, S107, 10.1038/sj.ki.4490858 · doi:10.1038/sj.ki.4490858
- Thomas, 2001, The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience., Semin. Oncol., 28, 60, 10.1016/S0093-7754(01)90215-5 · DOI
- Tonia, 2012, Erythropoietin or darbepoetin for patients with cancer., Cochrane Database Syst. Rev., 12, 10.1002/14651858.CD003407.pub5 · DOI · Paper page
- Toy, 2005, Transfusion-related acute lung injury: definition and review., Crit. Care Med., 33, 721, 10.1097/01.CCM.0000159849.94750.51 · DOI · Paper page
- Tsuboi, 2009, Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, phase III, randomized, double-blind, placebo-controlled study., Jpn. J. Clin. Oncol., 39, 163, 10.1093/jjco/hyn151 · DOI
- Tsui, 2014, Differential HIF and NOS responses to acute anemia: defining organ-specific hemoglobin thresholds for tissue hypoxia., Am. J. Physiol. Regul. Integr. Comp. Physiol., 307, R13, 10.1152/ajpregu.00411.2013 · DOI
- Turnbull, 1998, Mechanisms of hypothalamic-pituitary-adrenal axis stimulation by immune signals in the adult rat., Ann. N. Y. Acad. Sci., 840, 434, 10.1111/j.1749-6632.1998.tb09582.x · DOI
- Umemoto, 1997, Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells., Blood, 90, 3438, 10.1182/blood.V90.9.3438 · DOI · Paper page
- Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation., Science, 324, 1029, 10.1126/science.1160809 · DOI · Paper page
- Weber, 2008, Anemia and transfusions in patients undergoing surgery for cancer., Ann. Surg. Oncol., 15, 34, 10.1245/s10434-007-9502-9 · DOI
- Wish, 2006, Assessing iron status: beyond serum ferritin and transferrin saturation., Clin. J. Am. Soc. Nephrol., 1, S4, 10.2215/CJN.01490506 · DOI · Paper page
- Woodson, 1982, Effect of increased oxygen affinity and anemia on cardiac output and its distribution., J. Appl. Physiol., 53, 1299, 10.1152/jappl.1982.53.5.1299 · doi:10.1152/jappl.1982.53.5.1299
- Wright, 2007, Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia., J. Clin. Oncol., 25, 1027, 10.1200/JCO.2006.07.1514 · DOI · Paper page
- Wu, 2015, Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells., Sci. Rep., 5, 10.1038/srep12291 · DOI · Paper page
- Xia, 2018, The role of HIF-1α in chemo-/radioresistant tumors., Onco Targets Ther., 11, 3003, 10.2147/OTT.S158206 · DOI
- Zhang, 2017, Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a large-scale retrospective study., Cancer Med., 6, 2822, 10.1002/cam4.1233 · DOI
- Zhang, 2014, Impact of preoperative anemia on relapse and survival in breast cancer patients., BMC Cancer, 14, 10.1186/1471-2407-14-844 · DOI
- Zhu, 2015, Association of pretreatment anemia with pathological response and survival of breast cancer patients treated with neoadjuvant chemotherapy: a population-based study., PLoS One, 10, 10.1371/journal.pone.0136268 · DOI
Cited by
Hepcidin and Iron in Health and Disease
Nemeth, E., & Ganz, T. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-043021-032816 · Cited by 457
Metadata
- Authors
- Madeddu, C., Gramignano, G., Astara, G., Demontis, R., Sanna, E., Atzeni, V., & Macciò, A.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2018-09-20
- Volume
- 9
- Pages
- 1294-1294
- ISSN
- 1664-042X (ISSN-L)
- OpenAlex
- W2889138052
- Cited by
- 201
- References
- 19
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach. https://app.cochat.ai/papers/10.3389/fphys.2018.01294
- The paper
- Madeddu, C., Gramignano, G., Astara, G., Demontis, R., Sanna, E., Atzeni, V., & Macciò, A. (2018). Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach. Frontiers in Physiology. https://doi.org/10.3389/fphys.2018.01294
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.